Prot# IL13PEI-301: Phase III Randomized Evaluation of Convection Enhanced Delivery of IL13-PE38QQR Compared to Gliadel® Wafer with Survival Endpoint in Glioblastoma Multiforme Patients at First Recurrence (PRECISE Trial)

Project: Research project

Project Details

StatusFinished
Effective start/end date5/6/043/26/08

Funding

  • PPD Development (IL13PEI-301)
  • NeoPharm, Inc. (IL13PEI-301)